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Abstract
The actin cytoskeleton is central tomany cell processes includingmembrane trafficking and generation of cell
polarity. We have identified a role for actin in cell death and in promoting longevity of the budding yeast,
Saccharomyces cerevisiae. Aging in yeast appears to occur via an apoptotic-like pathway with changes
including DNA fragmentation, loss of mitochondrial membrane permeability, increase in levels of ROS
(reactive oxygen species) and exposure of phosphatidylserine in the outer leaflet of the plasma membrane.
This pathway can be induced by alterations in actin dynamics, such that reduced dynamics correlates with
increased levels of ROS and decreased viability. Conversely, increased actin dynamics correlates with low
ROS levels and increased survival. Our current studies have focused on identifying pathways which couple
changes in actin dynamics to cell death.
Introduction
The yeast actin cytoskeleton is an essential structure that is
organized into two major structures that can be visualized
by fluorescence microscopy of rhodamine phalloidin stained
cells [1]. Aligned along the mother bud axis are actin cables,
bundles of long actin filaments which serve as tracks for the
movement of secretory vesicles and organelles including
mitochondria, peroxisomes and vacuoles [2]. The other main
actin structures are the cortical actin patches. These are visual-
ized as small dots, which are highly polarized to the buds of
growing cells. Cortical actin patches are proposed to be sites
of endocytosis [3]. Both actin structures are disrupted by the
actin monomer-sequestering drug latrunculin-A, indicating
they are highly dynamic [4]. Indeed, the dynamic state of
F-actin is considered central to its ability to perform in all its
known functions in yeast. Addition of actin-stabilizing drugs,
or the introduction of mutations which reduce actin dy-
namics, both lead to decreased cell viability, indicating the im-
portance of maintaining the dynamic stage of the actin cyto-
skeleton. Our investigations into the effects of altering actin
dynamics have led us to demonstrate that such changes are
able to modulate the level of ROS (reactive oxygen species) in
a cell, and consequently to lead to cell death via an apoptotic-
like pathway [5].
There are two main reasons that advances in this field have
come from studies in yeast. First, there is a single actin gene
(ACT1) that can be readily mutated and expressed as the
sole form of actin in the cell [6]. Therefore it is possible to
study the effect of single-point mutations, and there are
a plethora of actin mutants that have been generated and
characterized [7]. Secondly, as in other eukaryotes, the
central organelle for the production of damaging ROS is
the mitochondrion. However, yeast are able to grow in both
fermentative and non-fermentative states, only the latter of
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which requires a functioning mitochondrion. So, defects that
disrupt mitochondria, and which in many other cell types
would be lethal, are open to study in this highly manipulable
organism.
Yeast apoptosis and aging
Yeast normally grows as a clonal colony and each cell is
surrounded by its own progeny. Each budding event leads
to a birth scar on the mother and eventually this impacts on
the integrity of the cell surface (the average wild-type cell can
produce approx. 25 daughter cells). Daughter cells selectively
inherit undamaged mitochondria [8] and receive new cell-
wall material [9] and so each daughter is effectively ‘born’ at
age 0. Continual exposure of a cell to ROS and the increasing
inability to withstand ROS with age results in the accumu-
lation of damaged cell components inmother cells. In order to
preserve her own gene pool it becomes more beneficial for a
mother cell to die than to utilize increasingly scarce nutrients
for her own growth.
As in mammalian cells, apoptotic yeast cells show mito-
chondrial depolarization, high levels of ROS, DNA fragmen-
tation and phospholipid exposure at the plasma membrane.
Exposure of yeast to low levels of hydrogen peroxide,
depletion of glutathione or expression of the mammalian bax
gene induces apoptosis, accompanied by an increase in ROS.
The role of the yeast caspase-like protein Yca1p is less clear,
although there is evidence that caspase-dependent cell-death
pathways are present and contribute to cell death [10]. Finally,
an apoptosis-inducing factor (Aif1) is present in yeast and
shares characteristics with its mammalian counterpart [11].
There are two main measures of aging in yeast: chronological
aging considers the longevity of non-dividing cells (this is
considered to be equivalent to post-mitotic aging in higher
eukaryotes) [12]; and replicative aging is an assessment of
the number of daughters generated from a mother cell [13].
In both cases, it is clear that build-up of ROS and redox
regulation is a key factor in determining lifespan [14,15].
Importantly, deletion of superoxide dismutase or catalase
genes shortens the lifespan of yeast, whereas the antioxidant
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Figure 1 Actin dynamics correlates with viability and production of ROS
Upper panels show the actin cytoskeleton stained with rhodamine-phalloidin in 5-day-old cultures of wild-type cells, act1-157
cells (exhibiting increased actin dynamics) and act1-159 cells (exhibiting reduced actin dynamics). Lower panels show, for
the same strains, flow cytometric analysis to measure H2O2 levels as an indicator of ROS accumulation. Beneath these panels
are the viabilities recorded for each strain.
glutathione increases yeast lifespan as a result of reducing
ROS levels.
Evidence that actin dynamics can trigger
yeast programmed cell death
The central finding of the studies in yeast is that changes that
decrease actin turnover, and that lead to the accumulation of
large aggregates of F-actin, trigger an increase in the levels
of ROS in the cytosol. Decreases in turnover could be in-
duced by specific point mutations in actin that affect nucleo-
tide exchange, by addition of the actin-stabilizing drug
jasplakinolide, and in aged cells (Figure 1) [5]. Conversely,
increased actin turnover, which can be induced by mutations
in actin or by deletion of the gene for the actin-bundling pro-
tein Scp1p, leads to decreased production ofROS and, in turn,
to increased viability [5]. Indeed, deletion of Scp1p is able to
increase lifespan in both dividing andnon-dividing yeast cells.
Importantly, disruption of mitochondrial function prevented
the accumulation of ROS in cells that exhibited reduced actin
dynamics, which demonstrated that mitochondria are the
source of the ROS. In addition, these cells still had aberrant
actin aggregates, which showed that changes in actin in the
absence of mitochondrial function do not themselves elicit
the cell-death phenotype. The fact that alterations in actin
dynamics can both increase and decrease levels of detectable
ROS has led to the hypothesis that the actin cytoskeleton
could act as a regulator for ROS release from the mito-
chondrion.
Mechanisms coupling changes in actin
dynamics to cell death
While the results strongly support the notion that changes in
actin dynamics are able to trigger an apoptotic-like path-
way, the mechanism that facilitates this outcome is not
known. There are a number of models that can be proposed
to explain the link. Two of these are outlined here (Figures 2A
and 2B). In essence, the link could be direct, i.e. actin could
directly regulate interactions with the mitochondria and
influence release of ROS. Alternatively, the link could be
indirect and actin could be viewed as a cytosolic sensor of
well-being within the cell.
Direct coupling of actin to mitochondrial function
There are known to be direct links between mitochondria
and F-actin, and mitochondria can be observed to align along
actin cables [16–18]. In addition, disruption of actin cables
results in altered mitochondrial morphology. Mitochondria
are also known to use actin cables as tracks to facilitate
inheritance by the daughter cell. Indeed, it has generally been
thought that themain reason for the association between actin
and mitochondria is to ensure movement into the new bud.
One interesting recent observation is that daughter cells in-
herit newly synthesized mitochondria, while mother cells
retain older, often damagedmitochondria [19] suggesting that
there could be selective interaction and movement of differ-
ent domains of the mitochondria. One mechanism that
would allow direct coupling of ROS release to actin func-
tion is by regulation of opening and closing of the VDACs
(voltage-dependent anion channels; Figure 2A). These are
mitochondrial membrane pores which regulate the release
of proapoptotic factors such as cytochrome c, and which
are important for maintaining the mitochondrial membrane
potential. Certainly, mammalian gelsolin, an actin regulatory
protein, is able to affect entry to apoptosis by its effects on
VDACs (see below). Interestingly, evidence also exists to
suggest that actin regulates VDAC closure in the filamentous
C©2005 Biochemical Society
1262 Biochemical Society Transactions (2005) Volume 33, part 6
Figure 2 Models for coupling actin dynamics to apoptosis
(A) Direct regulation of ion channels. Results indicate that actin can be
involved in the regulation of the VDAC, which has an important role in
apoptotic cell death. Opening and closure of the VDAC is involved in regu-
lating the permeability of the mitochondrial outer membrane. In an
open, or proapoptotic, state, which occurs when the actin cytoskeleton
is stabilized, the VDAC allows the release of apoptogenic proteins, such
as cytochrome c, from the mitochondria. Closure of the VDAC, in response
to a dynamic actin cytoskeleton, has been demonstrated to confer
resistance to apoptotic stimuli. (B) Actin as a sensor of cell well-being.
The Ras/cAMP pathway is highly conserved amongst eukaryotes. In
yeast cells, the small G-protein Ras2, a homologue of mammalian
oncogene Ras, regulates adenylate cyclase (Cyr1) that in turn catalyses
synthesis of cAMP from ATP. cAMP then activates protein kinase A
(PKA), which leads to the transcription of stress response genes. In
healthy cells, repression of the Ras/cAMP pathway on exposure to stress
appears to trigger remodelling of actin structures, which is proposed
to be important for survival. Cells with aggregated F-actin appear to
constitutively activate the Ras/cAMP pathway, which leads to elevated
cAMP levels, mitochondrial dysfunction, ROS accumulation and cell
death. In this situation, the Ras pathway no longer appears to be able to
trigger appropriate actin remodelling, suggesting a block in the normal
stress response pathway required to protect actin. Overexpression of
PDE2 that decreases cAMP levels is able to rescue the actin clumping
and also restores ROS to wild-type levels.
fungus, Neurospora crassa [20]. In purified mitochondria
from N. crassa, addition of an actin-stabilizing drug, phal-
loidin, caused prolonged opening of VDAC pores and an
increase in releasedROS, suggesting that actin has a conserved
role in cell death by regulating VDAC in eukaryotic
cells.
Stress signalling, actin and apoptosis: actin
dynamics as a sensor of cell well-being
Remodelling of the cytoskeleton in response to stress is a
fundamental process in many eukaryotic cells. As a less dy-
namic cytoskeleton is unable to respond effectively to stress,
it would be prudent in a population to remove cells with
this non-responsive cytoskeleton (either in a tissue or in a
colony of unicellular eukaryotes). Such a scenario requires
that cells are able to couple a signalling pathway involved in
cell viability to remodelling of the actin cytoskeleton, such
that the pathway both regulates, and is regulated by, actin
dynamics (Figure 2B). This pathway would determine
whether a cell is maintained in a population by using actin
dynamics as a biosensor of health. A recognized example
of a pathway fulfilling these requirements is the Ras/cAMP
pathway in Saccharomyces cerevisiae. In yeast, this pathway
is a regulator of longevity and its negative regulation (re-
pression) is essential for the response to environmental
stresses [21]. Constitutive activation of the Ras pathway
leads to a failure to up-regulate proteins that protect against
oxidative stress, to mitochondrial dysfunction and to a
reduced lifespan. An increase in lifespan has been noted in
cells lacking Ras, as they have elevated levels of proteins
that are involved in protecting against oxidative stress. The
Ras pathway has also been shown to play a role in actin
regulation [22]. Recent results support this idea and have
revealed that the Ras/cAMP pathway and actin are able to
interact to regulate oxidative stress and cell viability [23].
Cells that lack either of the two actin regulatory proteins,
End3p or Sla1p, form large aberrant F-actin aggregates and
also display phenotypes associated with overactivation of the
Ras/cAMP signalling cascade. These include mitochondrial
dysfunction, elevated ROS levels, reduced longevity and
a failure to respond to nutritional stress. In support of
Ras/cAMP overactivation as the cause of oxidative stress and
cell death in these actin regulatory mutants, overexpression
of PDE2 (phosphodiesterase 2), a negative regulator of the
Ras/cAMP pathway, can reduce ROS levels and restore
viability to wild-type levels [23]. Therefore the activity of the
Ras/cAMP pathway is responsive to the dynamic state of
the actin cytoskeleton in yeast. In turn, overexpression
of PDE2 in these mutant cells alleviates the formation of
actin aggregates indicating that the Ras/cAMP pathway also
regulates actin dynamics. This result supports a cross-talk
mechanism between the Ras/cAMP signalling pathway and
the actin cytoskeleton, whichmodulates cell survival in yeast.
Thus, less energetic, aged or mutated cells, which exhibit
reduced cytoskeletal dynamics, cannot function to feed sig-
nals back to the Ras pathway, and would be eliminated from
the population. Current studies are focusing on identifying
further elements of this cell-death pathway.
Actin, apoptosis and aging in
mammalian cells
Although the evidence from yeast studies clearly shows
that changes in actin can induce release of ROS from
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mitochondria, the case in mammalian cells is less clear and
some results present a conflicting picture. Part of the contro-
versymight lie in the diverse range of cell types that have been
investigated, and the assays used to detect cellular changes.
Other complications include the fact that several actin iso-
forms are expressed, a lack of available actin mutants and
that it is difficult to readily abrogate mitochondrial function.
However, there is now a significant amount of circumstantial
evidence that indicates a role for actin in triggering cell death
and, potentially, aging, and that this function can lie upstream
of mitochondrial ROS release.
A link between actin stabilization and aging is suggested
by the finding that several screens to identify biomarkers of
aging in mammalian cells have identified the SM22 protein
[24–26]. SM22, which is also known as transgelin, cross-links
actin filaments in vitro and is the mammalian homologue
of yeast Scp1p [27,28]. Just as studies in yeast have shown
that elevated Scp1p can cause inappropriate actin clumping
and cell death, so studies in mammalian cells have observed
that senescent cells have higher levels of SM22/transgelin.
Additionally, reduced levels of SM22 have been reported in
several tumour cell lines [29]. Further studies on yeast and
mammalian cells might now shed light on the process of cell
aging and, in particular, how this process is linked to the
normal apoptotic pathway of cell death.
Some of the clearest results supporting links between actin
and apoptosis pathways in mammalian cells come from
studies using drugs that affect actin turnover. As in yeast, the
addition of jasplakinolide induces very robust actin stabil-
ization and rapidly leads to the accumulation of large F-actin
aggregates.Concomitantwith this reduction in actin turnover
is the induction of a cell-death pathway [30,31]. While there
might be some variability between cell types as to whether
actin changes alone can induce apoptosis or whether there
need to be additional stimuli, it is clear that, as in yeast, actin
stabilization can induce cell death and this is mediated
through changes involving mitochondria.
The best-studied physiological regulator of actin that also
has a role in apoptosis is gelsolin. This protein is well charac-
terized in mediating actin reorganization in response to
changes in Ca2+ and phosphoinositides in vivo and has a
demonstrated role in cell motility [32]. Overexpression of
gelsolin has been shown to inhibit apoptosis in Jurkat cell
lines in response to conditions that otherwise induce
cell death [33]. Further investigation has revealed that gelso-
lin-mediated inhibition of apoptosis occurs by blocking the
loss of mitochondrial membrane potential and also by pre-
venting caspase activation. A fraction of gelsolin co-localizes
with mitochondria, indicating that its role in regulating
the mitochondrial potential might occur through a direct-
binding mechanism [34]. Recent studies using neuronal cells
have correlated the anti-apoptotic role of gelsolin with its
dynamic actions on the actin cytoskeleton, and have demon-
strated that the key role of gelsolin in protection from
apoptosis is its ability to enhance actin depolymerization [35].
Overexpression of gelsolin is likely to increase the turnover of
actin and reduce the overall stability of the actin cytoskeleton,
which makes the situation analagous to the effect of the
scp1 deletion or the actin-destabilizing mutation (act1-157)
in yeast [5].
Summary
The actin cytoskeleton is known to be crucial in mediating
cell responses to both internal and external signals. Central
to its function is its dynamic structure and its ability to
be reorganized into distinct structures that are suitable for
particular tasks within the cell. Defects in the ability to
regulate the dynamics of actin are therefore likely to have
detrimental effects on cell function. Therefore it may not be
surprising that a cell that has lost the ability to signal to, and
reorganize, its actin experiences a signal for cell death. The
exact role for actin in the pathway remains unclear. Whether
actin itself can regulate channels in the mitochondria and
directly regulate the onset of apoptosis, or whether the effect
of actin aggregation is sensed by the mitochondria through
indirect pathways, are two questions under investigation.
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